The lot number was reviewed for complaint trend, nonconforming report and capa.Devices met specification prior to release and no trends were noted.Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.
|
According to available information, this device required medication due to exposure.The device was implanted on (b)(6) 2022 during laparoscopic supracervical hysterectomy, sacrocervicopexy for stage 3 pelvic organ prolapse.Device exposure was detected on physical exam on (b)(6) 2022.This was an incidental finding and the patient was otherwise asymptomatic.The patient was prescribed vaginal estrogen but actually did not use it because her insurance didn't cover it.On (b)(6) 2022 the device exposure had spontaneously resolved.The patient was given a tube of estrogen from the clinic and instructed to use it regularly to prevent vaginal atrophy.The cause of the device exposure was deemed to be associated with vaginal atrophy.
|